Spine

RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti

CLEVELAND, Sept. 13 /PRNewswire/ — RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ).  The L-Ti was previously cleared as an interbody fusion device.

RSB Spine Chief Executive Officer John A. Redmond said: “We are excited about this new clearance. Because of our Bridging Flush Fit™ design, we have always been of the opinion that the InterPlate L-Ti can function as an interbody fusion device and/or anterior lumbar plate. The new product code also simplifies coding for surgeons, clarifying reimbursement for this type of zero profile implant.”

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at:http://www.rsbspine.com.

SOURCE RSB Spine, LLC

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button